Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination Product: SP-101 and doxorubicin Cohort 1
(D03899)		[2] Doxorubicin,
SP-101		[2] Doxorubicin hydrochloride ,
Doxorubicin (D03899) 💬 		--[1] 299 💬
2Combination Product: SP-101 and doxorubicin Cohort 2
(D03899)		[2] Doxorubicin,
SP-101		[2] Doxorubicin hydrochloride ,
Doxorubicin (D03899) 💬 		--[1] 299 💬
3Doxorubicin
(D03899)		[1] Doxorubicin[2] Doxorubicin hydrochloride ,
Doxorubicin (D03899) 💬 		--[6] 26, 28, 34, 65, 299, 331 💬
4Doxorubicin Hydrochloride
(D03899)		[1] Doxorubicin[2] Doxorubicin hydrochloride ,
Doxorubicin (D03899) 💬 		--[3] 26, 34, 331 💬
5Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
(D03899)		[3] Cyclophosphamide,
Doxorubicin,
Methotrexate		[6] Methotrexate ,
Cyclophosphamide ,
Doxorubicin hydrochloride ,
Methotrexate sodium ,
Doxorubicin (D03899),
Cyclophosphamide 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 65 💬
6Liposomal Doxorubicin
(D03899)		[1] Doxorubicin[2] Doxorubicin hydrochloride ,
Doxorubicin (D03899) 💬 		--[1] 331 💬